| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 11,194 | 14,664 | 17,196 | 21,825 | | Cost of Revenue | 6,533 | 7,513 | 8,835 | 12,652 | | | Gross Profit | 4,661 | 7,151 | 8,361 | 9,173 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,887 | 2,792 | 3,748 | 4,172 | | Non Recurring |
-
|
-
|
-
| (14) | | Others | 3,304 | 3,688 | 3,619 | 2,967 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,530) | 671 | 994 | 2,049 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,117 | (290) | 9 | 122 | | Earnings Before Interest And Taxes | 1,587 | 381 | 1,003 | 2,171 | | Interest Expense | 1,191 | 1,460 | 1,372 | 1,436 | | Income Before Tax | 396 | (1,078) | (370) | 735 | | Income Tax Expense | 508 | (104) | 167 | 428 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (112) | (975) | (537) | 307 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (112) | (975) | (537) | 307 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($112) | ($975) | ($537) | $307 |
|
0.02% Nasdaq 0.00%
Income Statement
